Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 EP385 | DOI: 10.1530/endoabs.70.EP385

1Centro Hospitalar e Universitário de S. João, Department of Endocrinology, Diabetes and Metabolism, Porto, Portugal; 2Hospital da Luz, Clínica do Porto, Porto, Portugal; 3Centro Hospitalar e Universitário de S. João, Department of gynaecology, Porto, Portugal; 4Centro Hospitalar e Universitário de S. João, Department of Pathology, Porto, Portugal

Introduction: Leydig stromal cell tumors are a subtype of steroid tumors that make up to less than 0.1% of the ovarian tumors. These neoplasms can affect women from all ages but are more frequent after menopause, being usually unilateral, benign and small sized. In around 75% of cases, these tumors produce androgenic hormones, causing oligomenorrhea and virilization.

Case report: A 39-year-old woman, nulligravid, with complains regarding androgenic alopecia, acne and hirsutism, associated with weight gain for the last 8 months. She referred menstrual irregularities with oligomenorrhea after stopping taking oral contraceptive 9 months ago. The objective examination revealed an androgenic facies and alopecia, dorsocervical adiposity, acanthosis nigricans and clitoromegaly. Blood analysis revealed total testosterone 10.52 ng/ml (0.06–0.82), estradiol 41.8 pg/ml (1.3–266), androstenedione 5.13 ng/ml (0.3–3.3), DHEA-S 246.6 µg/dl (60.9–337.0), prolactin 32.7 ng/ml (4.8–23.3), LH 0.61 mUI/ml (2.4–12.6), FSH 0.87 mUI/ml (2.1–12.6), with normal thyroid function and free 24 h urinary cortisol. The gynaecological transvaginal ultrasound revealed an heterogenous solid lesion in the left ovary with 15 × 15 × 16 mm of smooth margins. A pelvic magnetic resonance showed globosity of the central stroma of the left ovary and the abdominal CT did not reveal any adrenal pathologic findings. The patient was submitted to laparoscopic left adnexectomy that proceeded without complications. A microscopic analysis of the surgical specimen revealed a Leydig cell ovarian tumor. During the follow-up medical consultations 1 month and 4 months after surgery, there was a notorious improvement of the clinical hyperandrogenism (hirsutism, androgenic alopecia), with regularization of the menstrual cycles and normalization of the serum androgens.

Conclusion: Ovarian tumors that produce androgens are a diagnostic challenge that must be considered in the differential diagnosis of severe hyperandrogenism. This case report of a woman presenting with virilization signs, shows the importance of undertaking a careful gynecological exam, followed by measurements of serum androgens and abdominopelvic imaging to exclude androgen producing tumors of the ovaries or adrenals. The virilizing tumors of the ovaries are surgically treated, usually having good prognosis.

Volume 70

22nd European Congress of Endocrinology

05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.